Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
APDN - Applied Dna Sciences Inc
-0.81(-7.74%)9:00:00 PM 1/25/2021
Applied DNA Sciences, Inc. is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. The company's DNA-based technology is utilized in a variety of industries including: textiles/fashion, wine, musical instruments, and electronics. Luxury goods manufacturers use these products to identify counterfeit consumer goods and to ensure their products' authenticity, helping, in part, to stem the flow of counterfeit goods and eliminate the slavery that is often implicit in the production of fake goods.[citation needed]
Stock Chart


  • MACD is crossing MACD signal line at 0.2. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics

Related Peers

Stock news

    Applied DNA Promotes Judith Murrah to Chief Operating Officer

    Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah’s expanding range of responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations management. Ms. Murrah has been instrumental in the undertaki...

    Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing

    Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the "Assay Kit") identified COVID-19 positive samples that are variants distinct from the wild-type virus that has dominated the U.S. in the pandemic until now. The variants were identified as part of the Company’s safeCircleTM pooled surveillance testing service, which is powered by the Company’s Assay Kits. The Assay...

    Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing

    Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its safeCircle™ pooled surveillance testing service has seen a 158% increase in the daily average number of tests performed to date in January 2021 compared to December 2020. The increase is chiefly the result of the scale-up of certain testing contracts and from the acquisition of new clients. Launched in the fourth quarter of fiscal 2020 (ended Sep...

    Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per share, priced at-the-market under Nasdaq rules, resulting in total gross proceeds of approximately $15 million, before deducting the placement agent’s fees and other estimated offering expe...

    New Strong Sell Stocks for January 12th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

    Applied DNA Sciences (APDN): Next Stop, $18?

    Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Last Friday, Applied DNA Sciences (APDN) played by the rulebook. Shares more than doubled in the session after the FDA recognized the company’s Linea COVID-19 assay kit as having unique properties.The Linea COVID-19 assay has been identified as one of only two tests given Emergency Use Authorization (EUA) that could have the ability to detect certain SARS-CoV-2 mutations, including the one f...

    ROCE Insights For Applied DNA Sciences

    In Q4, Applied DNA Sciences (NASDAQ:APDN) posted sales of $314.00 thousand. Earnings were up 27.09%, but Applied DNA Sciences still reported an overall loss of $4.05 million. Applied DNA Sciences collected $431.52 thousand in revenue during Q3, but reported earnings showed a $3.19 million loss.What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's...